Related Experiment Videos
Estrogens in Coronary Artery Disease: Regulatory Concerns
1Division of Metabolic and Endocrine Drug Products, US Food and Drug Administration, 5600 Fisher's Lane, Rockville, MD 20857, USA.
American Journal of Therapeutics
|May 1, 1995
Abstract
No abstract available in PubMed .